Atlas Trials

A Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetic Characteristics of LC28-0126.

Clinical trial NCT03196804 · COMPLETED

Trial details

NCT number
NCT03196804
Sponsor
LG Chem
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2017-06-07
Primary completion
2017-11-15
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.